World Market for Molecular Diagnostics, 14th Edition
Description
The molecular diagnostics market remains a powerful growth engine within the global in vitro diagnostics (IVD) industry. Several years after the pandemic, demand continues to expand across infectious disease testing, cancer diagnostics, and transplant applications. Kalorama Information’s World Market for Molecular Diagnostics, 14th Edition delivers a comprehensive, data-driven analysis of this fast-evolving sector, examining the technologies, applications, and competitive dynamics shaping the market from 2025 to 2030.
As molecular techniques become increasingly integrated into routine clinical practice, this report provides essential insight into how innovations in diagnostics are enabling more precise disease detection, supporting personalized treatment strategies, and driving continued market expansion in both developed and emerging regions.
Report Features
Comprehensive Market Insights
Analyze global and regional molecular diagnostics markets at the manufacturer level, segmented by key application areas including infectious diseases, blood screening, cancer diagnostics, and histology. Market size estimates for 2025 and detailed forecasts through 2030 are provided, along with compound annual growth rates (CAGRs) for each segment.
Technology-Driven Market Evolution
Explore how core molecular technologies—including polymerase chain reaction (PCR), next-generation sequencing (NGS), and in situ hybridization (ISH)—are transforming diagnostic capabilities and expanding the role of molecular diagnostics in clinical settings worldwide.
Competitive Intelligence and Market Structure
Gain insight into the competitive landscape through profiles of major market participants such as Roche Diagnostics, Thermo Fisher Scientific, and Illumina, alongside emerging competitors. The report examines company performance, new product developments, partnerships, mergers and acquisitions, and evolving competitive strategies.
Research Parameters
World Market for Molecular Diagnostics, 14th Edition covers global and regional markets for molecular diagnostics IVD products, including systems, kits, and consumables. Market data reflect manufacturer revenues, with 2025 as the base year and forecasts extending through 2030.
The analysis is supported by extensive primary and secondary research, including interviews with IVD manufacturers, clinical laboratory professionals, and industry experts, in addition to information from government and trade publications, industry reports, company annual reports, and public filings.
As molecular techniques become increasingly integrated into routine clinical practice, this report provides essential insight into how innovations in diagnostics are enabling more precise disease detection, supporting personalized treatment strategies, and driving continued market expansion in both developed and emerging regions.
Report Features
Comprehensive Market Insights
Analyze global and regional molecular diagnostics markets at the manufacturer level, segmented by key application areas including infectious diseases, blood screening, cancer diagnostics, and histology. Market size estimates for 2025 and detailed forecasts through 2030 are provided, along with compound annual growth rates (CAGRs) for each segment.
Technology-Driven Market Evolution
Explore how core molecular technologies—including polymerase chain reaction (PCR), next-generation sequencing (NGS), and in situ hybridization (ISH)—are transforming diagnostic capabilities and expanding the role of molecular diagnostics in clinical settings worldwide.
Competitive Intelligence and Market Structure
Gain insight into the competitive landscape through profiles of major market participants such as Roche Diagnostics, Thermo Fisher Scientific, and Illumina, alongside emerging competitors. The report examines company performance, new product developments, partnerships, mergers and acquisitions, and evolving competitive strategies.
Research Parameters
World Market for Molecular Diagnostics, 14th Edition covers global and regional markets for molecular diagnostics IVD products, including systems, kits, and consumables. Market data reflect manufacturer revenues, with 2025 as the base year and forecasts extending through 2030.
The analysis is supported by extensive primary and secondary research, including interviews with IVD manufacturers, clinical laboratory professionals, and industry experts, in addition to information from government and trade publications, industry reports, company annual reports, and public filings.
Table of Contents
306 Pages
- Scope and Methodology
- Overview
- Size of Molecular Diagnostics Market
- Growth Areas in Molecular Diagnostics
- Recent Trends and Developments
- Other Developments in Molecular Diagnostics, 2024-2025
- Recent Product Introductions and Regulatory Approvals
- Market Size and Forecast by Segments
- Infectious Diseases
- NAT Blood Screening
- Molecular Histology and Cytology Diagnostics
- HPV
- Markets for Molecular Cancer Diagnostics
- Molecular Transplant Diagnostics
- Molecular Inherited Diseases Diagnostics
- Molecular Diagnostics Market Deals, Collaborations, Acquisitions
- Sequencing
- Lab Automation and Molecular Diagnostics
- Gene Editing Applications in Molecular Diagnostics
- Abbott Diagnostics
- Advanced Cell Diagnostics (Bio-Techne)
- Agena Bioscience
- Agendia BV
- Agilent Technologies (incl. Dako)
- Altona Diagnostics
- Amoy Diagnostics
- Applied Spectral Imaging
- ARUP Laboratories
- Asuragen Inc. (Bio-Techne)
- Becton, Dickinson & Co. (BD)
- Beijing Genomics Institute (BGI)
- Berry Genomics
- binx health
- Bio-Rad Laboratories, Inc.
- Biocartis
- Biodesix
- bioMérieux
- CareDx, Inc.
- Danaher
- DiaSorin
- Eiken Chemical
- Greiner Bio-One GmbH
- Grifols, S. A
- Hologic, Inc.
- Illumina, Inc.
- Meridian Bioscience Inc
- NanoString Technologies, Inc.
- Oxford Nanopore Technologies Ltd
- Promega Corporation
- Qiagen
- QuidelOrtho
- Revvity
- Roche Diagnostics
- Seegene
- Sekisui Diagnostics LLC
- Sherlock Biosciences
- Standard BioTools
- Thermo Fisher Scientific Inc.
- Vela Diagnostics
- Veracyte, Inc.
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


